This hospital stock could hit ₹1,000 over the next 12 months, Investec predicts with a 'buy' rating

KIMS, a prominent hospital chain in India, is currently trading below its historical peak, but Investec has assigned it a 'buy' rating. The brokerage firm predicts the stock could reach ₹1,000 within the next 12 months. This optimism is based on the company's strategy to improve its financial metrics, specifically its EBITDAM margin, which measures operating profit before interest, taxes, depreciation, amortization, and rent.

For investors, this forecast signals a potential turnaround for the company. The prediction relies on several operational improvements. As newer hospitals become fully operational, their contribution to overall revenue is expected to grow. Additionally, KIMS is focusing on expanding its presence in higher-paying markets and improving its mix of specialty services. These factors are anticipated to drive operational leverage, where increased revenue leads to disproportionately higher profits, thereby boosting the stock's value.